Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Indications/Uses

Patizra is indicated in adults for: the treatment of neovascular (wet) age-related macular degeneration (AMD) (see Pharmacology: Pharmacodynamics under Actions).
The treatment of visual impairment due to diabetic macular edema (DME).
The treatment of proliferative diabetic retinopathy (PDR).
The treatment of visual impairment due to macular edema secondary to retinal vein occlusion (RVO).
The treatment of visual impairment due to choroidal neovascularisation (CNV) secondary to pathologic myopia (PM).
Patizra is indicated in preterm infants for: the treatment of retinopathy of prematurity (ROP) (see Pharmacology: Clinical studies under Actions).

Patizra Indications/Uses

ranibizumab

Manufacturer:

Novartis Indonesia